We are live on ! Find out more
CCM

Chicago Capital Management Portfolio holdings

AUM $112M
1-Year Est. Return 76.54%
This Fund
S&P 500
This Quarter Est. Return
+20.43%
1 Year Est. Return
+76.54%
3 Year Est. Return
+294.65%
5 Year Est. Return
+1,991.46%
10 Year Est. Return
+177,846.73%
AUM
$147M
AUM Growth
+$35.2M
Cap. Flow
-$49.5M
Cap. Flow %
-33.67%
Top 10 Hldgs %
44.65%
Holding
49
New
18
Increased
–
Reduced
–
Closed
6

Top Buys

Rank Stock Value
1
CDTX
Cidara Therapeutics
CDTX
+$7.92M
2
JHG
Janus Henderson
JHG
+$7.74M
3
EXAS
Exact Sciences
EXAS
+$6.92M
4
ATXS
Astria Therapeutics
ATXS
+$6.33M
5
HOLX
Hologic
HOLX
+$6.21M

Top Sells

Rank Stock Value
1
VRNA
Verona Pharma
VRNA
+$13.8M
2
TRML
Tourmaline Bio
TRML
+$5.38M
3
PBBK
PB Bankshares
PBBK
+$2.8M
4
CCRD
CoreCard
CCRD
+$1.75M
5
CFSB
CFSB Bancorp
CFSB
+$588K

Sector Composition

Rank Sector Weight
1 Healthcare 21.17%
2 Technology 5.65%
3 Financials 5.57%
4 Real Estate 0.95%
5 Industrials 0.23%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CDTX
1
DELISTED
Cidara Therapeutics
CDTX
$8.17M 5.56%
+49,000
New +$7.92M
EXAS
2
DELISTED
Exact Sciences
EXAS
$6.56M 4.47%
+86,122
New +$6.92M
JHG
3
DELISTED
Janus Henderson
JHG
$6.26M 4.26%
+175,000
New +$7.74M
CFLT
4
DELISTED
Confluent
CFLT
$5.34M 3.63%
+235,300
New +$5.78M
ATXS
5
DELISTED
Astria Therapeutics
ATXS
$5.24M 3.56%
+530,000
New +$6.33M
HOLX
6
DELISTED
Hologic
HOLX
$4.78M 3.25%
+85,000
New +$6.21M
FOLD
7
DELISTED
Amicus Therapeutics
FOLD
$4.28M 2.92%
+400,000
New +$3.93M
HPE.PRC
8
Hewlett Packard Enterprise 7.625% Series C Preferred Stock
HPE.PRC
$3.7B
$2.19M 1.49%
32,900
– –
RNAM
9
DELISTED
Avidity Biosciences
RNAM
$1.91M 1.3%
+35,000
New +$2.26M
DAY
10
DELISTED
Dayforce
DAY
$1.8M 1.22%
+34,568
New +$2.38M
ALEX
11
DELISTED
Alexander & Baldwin
ALEX
$1.39M 0.95%
+90,000
New +$1.56M
SNCR
12
DELISTED
Synchronoss Technologies
SNCR
$1.17M 0.8%
+182,470
New +$1.13M
IROQ
13
DELISTED
IF Bancorp
IROQ
$1.02M 0.69%
+38,066
New +$994K
NWFL icon
14
Norwood Financial Corp
NWFL
$355M
$407K 0.28%
+15,069
New +$411K
GIFI
15
DELISTED
Gulf Island Fabrication
GIFI
$333K 0.23%
+36,819
New +$371K
FSFG
16
DELISTED
First Savings Financial Group
FSFG
$312K 0.21%
+12,977
New +$403K
EA icon
17
Electronic Arts
EA
$52.4B
$308K 0.21%
+2,000
New +$404K
BLFY
18
DELISTED
Blue Foundry Bancorp
BLFY
$185K 0.13%
+19,734
New +$197K
AVDL
19
DELISTED
Avadel Pharmaceuticals
AVDL
$163K 0.11%
+10,000
New +$194K
BFIN
20
DELISTED
BankFinancial
BFIN
– –
-28,752
Closed -$346K
CCRD
21
DELISTED
CoreCard
CCRD
– –
-65,059
Closed -$1.75M
CFSB
22
DELISTED
CFSB Bancorp
CFSB
– –
-41,424
Closed -$588K
PBBK
23
DELISTED
PB Bankshares
PBBK
– –
-145,751
Closed -$2.8M
TRML
24
DELISTED
Tourmaline Bio
TRML
– –
-112,406
Closed -$5.38M
VRNA
25
DELISTED
Verona Pharma
VRNA
– –
-129,600
Closed -$13.8M

Similar funds

PC
Parrish Capital Kennesaw, Georgia $112M AUM
PFS
Professional Financial Solutions Falls Chruch, Virginia $112M AUM
VCM
Veradace Capital Management Dallas, Texas $112M AUM
DM
Diker Management New York $112M AUM 59.78% 1-Year Est. Return
AIC
Argus Investors Counsel New York $112M AUM 25.83% 1-Year Est. Return
APFP
Action Point Financial Planning Grand Rapids, Michigan $112M AUM
AIP
Arrowpoint Investment Partners Singapore $113M AUM 73.91% 1-Year Est. Return
MWP
Momentum Wealth Planning Estero, Florida $113M AUM 26.08% 1-Year Est. Return

Chicago Capital Management's Q4 2025 Portfolio in Review

As of Q4 2025, Chicago Capital Management held 49 positions worth $147M, up 31% from $112M the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Chicago Capital Management withdrew a net $49.5M in Q4 2025, closing 6 positions. Its most notable exit was Verona Pharma, an estimated $13.8M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 17% a quarter earlier, followed by Technology and Financials.

Against the trend, Chicago Capital Management opened a new position in Cidara Therapeutics worth $8.17M.

  • Chicago Capital Management's largest Q4 2025 buy was Cidara Therapeutics: 49,000 shares worth $8.17M.
  • Chicago Capital Management fully exited Verona Pharma in Q4 2025, selling an estimated $13.8M.
  • Chicago Capital Management's ten largest holdings make up 45% of its $147M portfolio in Q4 2025.
  • Chicago Capital Management opened 18 new positions and closed 6 in Q4 2025.
  • Chicago Capital Management's portfolio value rose 31% quarter-over-quarter to $147M.

Based on Chicago Capital Management's 13F filing for Q4 2025, filed 2 Feb 2026.